There has been a dramatic increase in recent years in the incidence of Barrett's oesophagus
and the oesophageal adenocarcinoma associated with it. Adequate monitoring strategies …

Since Barrett's esophagus is a precancerous condition, efforts have been made for its
eradication by various ablative techniques. Initially, laser ablation was attempted in non …

Background: Endoscopic resection (ER) has gained more and more importance in the
treatment of early neoplasia in Barrett's esophagus. As long as there has been no long-term …

Recent retrospective cohort data and a prospective randomized sham controlled trial have
clearly documented the impact of endoscopic ablation therapy on dysplasia and Barrett's …

There have been major recent advances in the understanding of the pathogenesis and
epidemiology of Barrett's esophagus and adenocarcinoma of the esophagus. The advent of …

Endoscopic therapy of early Barrett's oesophagus–related neoplasia is the treatment of
choice for low-grade-dysplasia, high-grade dysplasia and mucosal Barrett's cancer. Low …

Both the incidence of esophageal adenocarcinoma (EA) and its precursor, Barrett's
esophagus (BE) is increasing rapidly in the western world. The progression of BE to EA …

This chapter will review the endoscopic approaches to the management of Barrett's
oesophagus with high-grade dysplasia/early mucosal cancer. Factors to consider when …

Barrett's esophagus (BE) is an important risk factor for esophageal carcinoma and its
incidence is rising. Amongst the various available endoscopic ablative therapies …

BACKGROUND: Endoscopic therapies for early neoplasia in Barrett's esophagus may be a
viable alternative to esophagectomy. OBJECTIVE: Our purpose was to compare endoscopic …